Seeking Alpha

Galena reports today after the close

  • Controversial biotech Galena Biopharma (GALE) will report Q4 and 2013 results after today's close.
  • Consensus estimates for the quarter are a loss of $0.09/share on revenues of $1.6M. Estimates for the year are a loss of $0.41/share on revenues of $2.7M.
  • Consensus views for 2014 are a loss of $0.36/share on revenues of $12.6M.
  • 96 mutual funds have positions, up from 27 a year earlier.
  • Shares are up 7% premarket.
Comments (3)
  • GlennLangohr
    , contributor
    Comments (35) | Send Message
    Galena should have good numbers with Abstral market share. Hopefully strong guidance and as reasonable explanation of the publicity scandal as possible.
    17 Mar, 12:14 PM Reply Like
  • parvin
    , contributor
    Comments (2) | Send Message
    Does anyone have confirmation of the earnings release and conference call? Please post the phone number if you have one.
    17 Mar, 01:42 PM Reply Like
  • User 8154791
    , contributor
    Comments (2) | Send Message
    Apparently no conference call today.
    17 Mar, 05:14 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio: